Clarkston Capital Partners, LLC Tandem Diabetes Care Inc Transaction History

Clarkston Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$53.22 - $123.09 $106,440 - $246,180	-2,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $23,399 - $30,335	198 Added 10.99%	2,000 $301,000
Q3 2021 Nov 10, 2021	BUY	$93.51 - $129.4 $168,505 - $233,178	1,802 New	1,802 $215,000
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $172,800 - $243,500	-2,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $190,860 - $232,180	2,000 New	2,000 $227,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Clarkston Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Clarkston Capital Partners, LLC with notifications on news.